Towards a Food Ingredient Clinically Proven to Benefit Gut Health: Novel RG-I Variants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The aim of this study is to determine, quantify and understand the potential prebiotic effects of RG-I variants via microbiota modulation. The anti-inflammatory potential effects of these variants will also be investigated.
Epistemonikos ID: f1681b7824e8892bc6248aa10a05a88239ec997a
First added on: May 15, 2024